To test the potential pro-carcinogenic effects of CCL20 and CCR6 in lung cancer, we first aimed to characterize the expression and tissue localization of this chemokine/chemokine receptor pair in NSCLC tumors. Here, CCR6 is linked to lung carcinoma.